Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. - Wikidata - wikimedia - TriplyDB

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

http://www.wikidata.org/entity/Q34112179

about

Neuroplasticity and the next wave of antidepressant strategies Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Practical application of the neuroregenerative properties of ketamine: real world treatment experience Kynurenine pathway metabolites and suicidality Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants Pharmacological approaches to the challenge of treatment-resistant depression Antidepressant mechanism of ketamine: perspective from preclinical studies The role of inflammation in suicidal behaviour Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Antidepressant actions of ketamine: from molecular mechanisms to clinical practice Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Ketamine for treatment-resistant unipolar depression: current evidence Cell atrophy and loss in depression: reversal by antidepressant treatment Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy A brief history of the development of antidepressant drugs: from monoamines to glutamate Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice.R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Acute D-serine treatment produces antidepressant-like effects in rodents Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.From synapse to nucleus: novel targets for treating depression.Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Therapeutic infusions of ketamine: do the psychoactive effects matter?The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers.Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.Pharmacogenomics of suicidal events.

P2860

Q21129480-FB58C1F4-570D-413B-9B14-111BB8C243AF Q24629398-30CA0E98-D39E-4BAD-A948-6F2F04B2ED75 Q26748766-B14F7B17-3237-44D9-9F03-27E9E7337736 Q26773067-3DFE86AD-069F-438D-99E8-1DD4B1E7CD91 Q26778251-07D7303E-19D5-4FBF-B6D8-DF34E3E2CD64 Q26782274-120C37F6-F21C-4C88-9BE1-7930CED416AD Q26798241-8BC685F5-DA15-4795-9858-305BB88187A5 Q26800231-1E9F147C-4B17-4079-A1E4-6E80AF5F42DE Q26800426-3A349941-2AAE-4ED7-8FA8-8337559B7530 Q26829556-1301FF46-F692-44C6-BC17-A8AF340449CA Q26995879-0B29B90E-D3EB-4FCC-A741-306DFEB52430 Q27001628-3EADCD9B-2A6E-462C-8A2D-690383BDB9F3 Q27004490-E72EC28B-99A6-4EAB-8DBB-3ADCBB4EC74F Q27004508-B38D55E2-25DA-452C-BBAF-58EEB007C9A0 Q27013609-190AF423-E5EC-45C9-993C-10082976C009 Q27024227-88DB441B-14FB-4461-965C-E28A5B9C4433 Q27028050-8B946ACD-128B-4C4F-B7B4-7BDAE2ED8C6F Q27300750-5126395C-B2ED-4135-8801-4B1A2079BAA8 Q28266846-F2A38422-A515-418A-A921-4E07B4EA4FB7 Q28276943-1B4DEB22-5989-4E3A-92C1-B78D8779E663 Q28476686-5B723DF1-9D60-445F-A190-46FD6D2DD2C6 Q28820763-BCD7A912-06B4-4C0F-B7DB-B298E8831E51 Q30423149-9E80E256-4C4F-4577-A6E1-89A3BB249AC3 Q30440925-39EAFD82-7619-49B0-B695-271C45E1F64F Q30471587-17E449E1-A00D-4738-9262-2902C3539A78 Q30505292-9A0E9124-7A58-4FE5-84AA-E70F377718EF Q30508512-4F211534-47C8-413E-8A9F-553D2D073031 Q30580921-B205FF73-25B4-4090-B0EE-0C217E89626C Q30711088-750EC0A9-B8CD-4EE4-AEB3-E09DAE7AB6F3 Q33604879-8E2127FA-32B1-4E3D-9B5F-AFA356B96E86 Q33653177-9ECBD66B-F339-417C-8BE8-4238EB1EC0C4 Q33848833-65DFD903-D750-4368-884D-63AA3D3D55D9 Q33864745-9B4784E9-1BF7-4A5F-A266-41EEEC08CA39 Q33874459-71CD8489-0461-4942-BF78-46E6BF02549F Q33880853-3B7554A5-A73B-49EC-8F4E-02EB1483C15A Q33926787-69F2B742-A1B8-48AC-AE5E-4DEA648DBA8B Q33956313-F2E452F1-FED5-40B4-B5F7-021325667553 Q34043478-D2A74B4A-F9AD-402E-92DC-EC871978D6BE Q34061150-71F7E4EF-F1E4-4C10-99EF-8DFB32C1F412 Q34066818-3D1472B6-B112-40F2-90DB-BBE1F3B2052B

P2860

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

http://www.wikidata.org/entity/Q34112179

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of intravenous ketamin ...... reatment-resistant depression.

@ast

Effects of intravenous ketamin ...... reatment-resistant depression.

@en

Effects of intravenous ketamin ...... reatment-resistant depression.

@nl

type

label

Effects of intravenous ketamin ...... reatment-resistant depression.

@ast

Effects of intravenous ketamin ...... reatment-resistant depression.

@en

Effects of intravenous ketamin ...... reatment-resistant depression.

@nl

prefLabel

Effects of intravenous ketamin ...... reatment-resistant depression.

@ast

Effects of intravenous ketamin ...... reatment-resistant depression.

@en

Effects of intravenous ketamin ...... reatment-resistant depression.

@nl

P1433

Q34112179-C5BB3A83-2DC7-446D-AC83-4981CFD758E9

P1476

Q34112179-5C5A1958-3AAF-4EC8-8557-5C3902B21C8E

P2093

Q34112179-400D1497-5D9A-47E7-9EB7-74C625EC7102

Q34112179-85AA8F14-B8CD-4BEE-A25E-3D76E7B3A62D

Q34112179-8AD9A249-3EB1-4448-BC31-A4C4FC35969F

P2860

Q34112179-0C959ECC-C0E5-4783-83BA-633C2D7C626D

Q34112179-5137BDAB-3BAF-4A7C-9077-10EF3BD6E76F

Q34112179-5317B160-36D2-4567-97A7-FE3B459BDCA0

Q34112179-56762919-8DF3-424B-8628-4E7B99570900

Q34112179-5CA902B8-6C23-4709-A951-FE6959A500D9

Q34112179-6A6B7414-A493-44FC-9820-9337A9DAD541

Q34112179-8C454848-A2B9-472C-A645-F7FF9E17DD9E

Q34112179-9280A82D-D127-4C90-B4F8-EF09ADFCFD9F

Q34112179-AC01F1BD-1F62-4C98-9E3D-29F76385E388

Q34112179-B182293D-8A39-4FE4-A1E1-0B2DAC2C4734

P304

Q34112179-E18D6C39-110E-4784-8C4B-36DD03A9FE26

P31

Q34112179-04836405-8231-43E4-B309-39DE92EDB838

P356

Q34112179-2E175773-7591-441D-AB42-B0799C25E90E

P407

Q34112179-DDE4252F-3987-41D8-B1E6-F299DF565836

P433

Q34112179-BD831786-9A6A-4DF2-A0E5-6BE85092A0B5

P478

Q34112179-15268105-97F8-44E5-A25B-57A7115B283E

P50

Q34112179-119C088E-9DBE-49B4-BB0D-86B30B981BDA

P577

Q34112179-D16365C4-83A5-49B6-BF2B-63717FA5C4F1

P5875

Q34112179-31AFEC35-9CE1-49D4-B67D-9A1D436AABDA

P698

Q34112179-6EA3D63A-61E1-441F-B4A9-DE35BBF05079

P921

Q34112179-1AB8D983-1231-4A4F-806A-3D8E1F4F6CF3

Q34112179-65E9DFC1-8249-4178-AEE4-A0A682096EE1

Q34112179-928AA874-E5B4-44F3-813C-1DBE191C0D64

P932

Q34112179-68287F16-AD78-4FBC-8879-60B3AAF05D64

P356

J.BIOPSYCH.2009.04.029

P1433

Biological Psychiatry

P1476

Effects of intravenous ketamin ...... reatment-resistant depression.

@en

P2093

Dennis S Charney

http://www.w3.org/2001/XMLSchema#string

Rebecca B Price

http://www.w3.org/2001/XMLSchema#string

Sanjay J Mathew

http://www.w3.org/2001/XMLSchema#string

P2860

A new depression scale designed to be sensitive to change

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Understanding and using the Implicit Association Test: II. Method variables and construct validity.

The definition and meaning of treatment-resistant depression.

Prediction of suicide ideation and attempts among adolescents using a brief performance-based test.

Relief of expressed suicidal intent by ECT: a consortium for research in ECT study.

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity.

Implicit attitude measures: consistency, stability, and convergent validity.

P304

522-526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2009.04.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Matthew K. Nock

P577

2009-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26310437

http://www.w3.org/2001/XMLSchema#string

P698

19545857

http://www.w3.org/2001/XMLSchema#string

P921

suicide prevention

P932

2935847

http://www.w3.org/2001/XMLSchema#string